These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14998484)

  • 1. c-maf in multiple myeloma: an oncogene enhancing tumor-stroma interactions.
    Kienast J; Berdel WE
    Cancer Cell; 2004 Feb; 5(2):109-10. PubMed ID: 14998484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.
    Hurt EM; Wiestner A; Rosenwald A; Shaffer AL; Campo E; Grogan T; Bergsagel PL; Kuehl WM; Staudt LM
    Cancer Cell; 2004 Feb; 5(2):191-9. PubMed ID: 14998494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines.
    Moreaux J; Hose D; Jourdan M; Reme T; Hundemer M; Moos M; Robert N; Moine P; De Vos J; Goldschmidt H; Klein B
    Haematologica; 2007 Jun; 92(6):803-11. PubMed ID: 17550853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human.
    Morito N; Yoh K; Fujioka Y; Nakano T; Shimohata H; Hashimoto Y; Yamada A; Maeda A; Matsuno F; Hata H; Suzuki A; Imagawa S; Mitsuya H; Esumi H; Koyama A; Yamamoto M; Mori N; Takahashi S
    Cancer Res; 2006 Jan; 66(2):812-9. PubMed ID: 16424013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.
    Rasmussen T; Knudsen LM; Dahl IM; Johnsen HE
    Leuk Lymphoma; 2003 Oct; 44(10):1761-6. PubMed ID: 14692531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
    Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
    J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin.
    Mao X; Stewart AK; Hurren R; Datti A; Zhu X; Zhu Y; Shi C; Lee K; Tiedemann R; Eberhard Y; Trudel S; Liang S; Corey SJ; Gillis LC; Barber DL; Wrana JL; Ezzat S; Schimmer AD
    Blood; 2007 Dec; 110(12):4047-54. PubMed ID: 17875808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of small compounds that inhibit multiple myeloma proliferation by targeting c-Maf transcriptional activity.
    Asano K; Kikuchi K; Takehara M; Ogasawara M; Yoshioka Y; Ohnishi K; Iwata A; Shimizu S; Tanaka M
    Biochem Biophys Res Commun; 2023 Dec; 684():149135. PubMed ID: 37879249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages.
    Cao S; Liu J; Song L; Ma X
    J Immunol; 2005 Mar; 174(6):3484-92. PubMed ID: 15749884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
    Glassford J; Rabin N; Lam EW; Yong KL
    Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappa B p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome.
    Valanciuté A; le Gouvello S; Solhonne B; Pawlak A; Grimbert P; Lyonnet L; Hue S; Lang P; Remy P; Salomon R; Bensman A; Guellaën G; Sahali D
    J Immunol; 2004 Jan; 172(1):688-98. PubMed ID: 14688382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AhR- and c-maf-dependent induction of beta7-integrin expression in human macrophages in response to environmental polycyclic aromatic hydrocarbons.
    Monteiro P; Gilot D; Le Ferrec E; Lecureur V; N'diaye M; Le Vee M; Podechard N; Pouponnot C; Fardel O
    Biochem Biophys Res Commun; 2007 Jun; 358(2):442-8. PubMed ID: 17490615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues.
    Chen G; Xu X; Tong J; Han K; Zhang Z; Tang J; Li S; Yang C; Li J; Cao B; Zhou H; Wu D; Moran MF; Mao X
    Int J Biochem Cell Biol; 2014 Dec; 57():157-66. PubMed ID: 25448412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity.
    Lai R; Medeiros LJ; Wilson CS; Sun NC; Koo C; McCourty A; Brynes RK
    Mod Pathol; 1998 Jul; 11(7):642-7. PubMed ID: 9688185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma.
    Mansoor A; Akhter A; Pournazari P; Mahe E; Shariff S; Farooq F; Elyamany G; Shahbani-Rad MT; Rashid-Kolvear F
    Appl Immunohistochem Mol Morphol; 2015; 23(5):327-33. PubMed ID: 25265432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of primary MAFB target genes in multiple myeloma.
    van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
    Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
    Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
    Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and differential expression of the c-maf gene in differentiating cultured cells.
    Serria MS; Ikeda H; Omoteyama K; Hirokawa J; Nishi S; Sakai M
    Biochem Biophys Res Commun; 2003 Oct; 310(2):318-26. PubMed ID: 14521912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.